Clinical Trial Update: Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain [Phase 3]

View source ↗

Summary

Phase 3 trial update for CAM2038 (buprenorphine) in adults with recent moderate to severe chronic low back pain; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lower Back Pain
• Pain

Drugs mentioned

• CAM2038 (buprenorphine)

Snippet

Sponsor: Braeburn Pharmaceuticals | Conditions: Chronic Lower Back Pain, Chronic Pain | Phase 3 | Status: COMPLETED | Results posted: 2021-10-15